← Back to Search

HOP'N After-School Program for Obesity Prevention (HOP'N Trial)

Phase 4
Waitlist Available
Led By David A Dzewaltowski, Ph.D.
Research Sponsored by Kansas State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six times yearly
Awards & highlights

HOP'N Trial Summary

This study presents evaluates the effectiveness of the Healthy Opportunities for Physical Activity(HOP'N) After-School Program on preventing obesity in children. The investigators hypothesized that normal and overweight/obese children attending after-school sites randomized to the control condition will increase in weight status to a greater extent compared to children at sites randomized to receive the HOP'N program. The investigators also hypothesized that after-school intervention HOP'N sites will increase in physical activity and healthful eating opportunities compared to control sites.

Eligible Conditions
  • Obesity Prevention

HOP'N Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six times yearly
This trial's timeline: 3 weeks for screening, Varies for treatment, and six times yearly for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Mass Index Z-Score
Secondary outcome measures
physical activity

HOP'N Trial Design

1Treatment groups
Experimental Treatment
Group I: HOP'N After-School ProgramExperimental Treatment1 Intervention
After-school program with daily physical activity following CATCH guidelines, daily fruit/vegetable snack, and weekly nutrition and physical activity education based on social cognitive theory.

Find a Location

Who is running the clinical trial?

Kansas State UniversityLead Sponsor
35 Previous Clinical Trials
12,944 Total Patients Enrolled
Iowa State UniversityOTHER
59 Previous Clinical Trials
144,280 Total Patients Enrolled
David A Dzewaltowski, Ph.D.Principal InvestigatorKansas State University
2 Previous Clinical Trials
2,697 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby May 2025